Fuyuhiko Tamanoi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Walled Carbon Nanotubes

Mesenchymal Stem Cells

Top Venues

Nanoscale advances

This page only lists publications with an associated author ORCID identifier.

Publications

Mathilde Laird, Kotaro Matsumoto, Yuya Higashi, Aoi Komatsu, Art Raitano, Kendall Morrison, Minoru Suzuki, Fuyuhiko Tamanoi
Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy. Nanoscale advances 5 (9) (2023)
Mathilde Laird, Kotaro Matsumoto, Yuya Higashi, Aoi Komatsu, Art Raitano, Kendall Morrison, Minoru Suzuki, Fuyuhiko Tamanoi
Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy. Nanoscale advances 5 (9) (2023)
Mathilde Laird, Kotaro Matsumoto, Yuya Higashi, Aoi Komatsu, Art Raitano, Kendall Morrison, Minoru Suzuki, Fuyuhiko Tamanoi
Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy. Nanoscale advances 5 (9) (2023)
Yuya Higashi, Shuji Ikeda, Kotaro Matsumoto, Shinsuke Satoh, Aoi Komatsu, Hiroshi Sugiyama, Fuyuhiko Tamanoi
Tumor Accumulation of PIP-Based KRAS Inhibitor KR12 Evaluated by the Use of a Simple, Versatile Chicken Egg Tumor Model. Cancers 14 (4) (2022)
Aoi Komatsu, Kotaro Matsumoto, Yuki Yoshimatsu, Yooksil Sin, Arisa Kubota, Tomoki Saito, Ayaka Mizumoto, Shinya Ohashi, Manabu Muto, Rei Noguchi, Tadashi Kondo, Fuyuhiko Tamanoi
The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision Medicine. Cells 10 (10) (2021)
Miguel Gisbert-Garzarán, Daniel Lozano, Kotaro Matsumoto, Aoi Komatsu, Miguel Manzano, Fuyuhiko Tamanoi, María Vallet-Regí
Designing Mesoporous Silica Nanoparticles to Overcome Biological Barriers by Incorporating Targeting and Endosomal Escape. ACS applied materials & interfaces 13 (8) (2021)
Fuyuhiko Tamanoi, Shanmugavel Chinnathambi, Mathilde Laird, Aoi Komatsu, Albane Birault, Takushi Takata, Tan Le Hoang Doan, Ngoc Xuan Dat Mai, Arthur Raitano, Kendall Morrison, Minoru Suzuki, Kotaro Matsumoto
Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy. International journal of molecular sciences 22 (5) (2021)
Ngoc Xuan Dat Mai, Albane Birault, Kotaro Matsumoto, Hanh Kieu Thi Ta, Soontaree Grace Intasa-Ard, Kendall Morrison, Phan Bach Thang, Tan Le Hoang Doan, Fuyuhiko Tamanoi
Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug. ChemMedChem 15 (7) (2020)
Shanmugavel Chinnathambi, Fuyuhiko Tamanoi
Recent Development to Explore the Use of Biodegradable Periodic Mesoporous Organosilica (BPMO) Nanomaterials for Cancer Therapy. Pharmaceutics 12 (9) (2020)
Fuyuhiko Tamanoi, Kotaro Matsumoto, Tan Le Hoang Doan, Ayumi Shiro, Hiroyuki Saitoh
Studies on the Exposure of Gadolinium Containing Nanoparticles with Monochromatic X-rays Drive Advances in Radiation Therapy. Nanomaterials (Basel, Switzerland) 10 (7) (2020)
Aoi Komatsu, Kotaro Matsumoto, Tomoki Saito, Manabu Muto, Fuyuhiko Tamanoi
Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues. Cells 8 (5) (2019)
Jeffrey J Heard, Ivy Phung, Mark I Potes, Fuyuhiko Tamanoi
An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation. BMC cancer 18 (1) (2018)